Hy-Vee offering Pfizer-BioNTech COVID-19 booster vaccines for 12-15

Local News


Hy-Vee announced in a press release that free Pfizer-BioNTech COVID-19 vaccine booster doses are available by appointment only to 12- to 15-year-olds at least 5 months after their second dose. Additionally, the U.S. Food & Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) authorized the following:

All individuals who completed a primary series (two doses) of the Pfizer-BioNTech COVID-19 vaccine can receive an mRNA booster dose (Pfizer-BioNTech or Moderna) at least 5 months after their second dose (reduced from the previously authorized 6 months). 

Individuals ages 5 to 11 who are moderately to severely immunocompromised may receive a third dose of the Pediatric Pfizer-BioNTech COVID-19 vaccine at least 28 days after the second dose. At this time, Pediatric Pfizer-BioNTech booster vaccines are NOT authorized for individuals ages 5 to 11. 

Food & Drug Administration

Those who completed their primary COVID-19 vaccination with Moderna or received a mixed primary series can only receive a booster dose at least 6 months after their second dose. Patients ages 12 to 17 receiving a booster dose cannot mix-and-match vaccines. A parent or legal guardian must consent and accompany all minors to their vaccination. The booster vaccines are free to all eligible patients, regardless of insurance coverage. 

According to the release:

The second dose of the Pfizer-BioNTech vaccine should be administered at least 21 days after the first dose. A booster dose of the Pfizer-BioNTech vaccine is ONLY available for individuals ages 12 and older, and should be administered based on individuals’ primary vaccine manufacturer.


At least 5 months after the second dose if a Pfizer-BioNTech vaccine recipient (or at least 5 months after their third dose of Pfizer-BioNTech if moderately to severely immunocompromised)

At least 6 months after the second dose if a Moderna vaccine recipient (or at least 6 months after their third dose of Moderna if moderately to severely immunocompromised)

At least 2 months after the Janssen (Johnson & Johnson) dose if a Janssen vaccine recipient


For more information about COVID-19 vaccines or to make an appointment, click here

Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories